➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
Harvard Business School
Express Scripts
McKesson
Moodys
Mallinckrodt

Last Updated: June 7, 2020

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 020416


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

NDA 020416 describes FERIDEX I.V., which is a drug marketed by Amag Pharms Inc and is included in one NDA. Additional details are available on the FERIDEX I.V. profile page.

The generic ingredient in FERIDEX I.V. is ferumoxides. Additional details are available on the ferumoxides profile page.
Summary for 020416
Tradename:FERIDEX I.V.
Applicant:Amag Pharms Inc
Ingredient:ferumoxides
Patents:0
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrengthEQ 11.2MG IRON/ML
Approval Date:Aug 30, 1996TE:RLD:No

Expired US Patents for NDA 020416

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996   Start Trial   Start Trial
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996   Start Trial   Start Trial
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996   Start Trial   Start Trial
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996   Start Trial   Start Trial
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996   Start Trial   Start Trial
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996   Start Trial   Start Trial
Amag Pharms Inc FERIDEX I.V. ferumoxides INJECTABLE;INJECTION 020416-001 Aug 30, 1996   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Boehringer Ingelheim
AstraZeneca
Johnson and Johnson
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.